AI-generated analysis. Always verify with the original filing.
Elevance Health, Inc. disclosed under Item 7.01 that its officers expect to speak with investors and analysts over the next week during these meetings.
Key Takeaways
1Officers of Elevance Health, Inc. expect to speak with investors and analysts
2Meetings scheduled over the next week from filing date 2026-03-10
Current Report Details
Event Type
Regulation Fd
Disclosure
Voluntary
Variant
8-K
Items Reported
7.01
Regulation FD Disclosure Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts over the next week. During these meetings